Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REZAFUNGIN vs RIFAMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REZAFUNGIN vs RIFAMYCIN: Safety Overview

Metric REZAFUNGIN RIFAMYCIN
Total FAERS Reports 108 106
Deaths Reported 12 26
Death Rate 11.1% 24.5%
Hospitalizations 20 35
Average Patient Age 53.8 yrs 56.1 yrs
% Female Patients 54.3% 54.5%
FDA Approval Date Mar 22, 2023 Nov 16, 2018
Manufacturer Melinta Therapeutics, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Discontinued